UnitedHealth: Fundamentals Are Healing, Now the Chart Must Agree

[FXOpen]

UnitedHealth finds itself in a genuinely split narrative right now, trading near $388, down about 15.9% from its 52-week high, even as the fundamental picture keeps improving. Q2 earnings beat expectations, with revenue of $112.03 billion, and the company followed through with a significant policy shift: lifting prior-authorization requirements on roughly 1,700 diagnostic codes starting October 1, a move that could meaningfully ease administrative friction with providers and support margins going forward.

Wall Street's conviction has only grown stronger as a result. Wells Fargo and Bernstein both reaffirmed Buy ratings this month, with price targets near $526 and $512 respectively, while the broader consensus, a Moderate Buy across 27 analysts, points to an average target of $456.56, implying roughly 17% upside from current levels.

The stock has nonetheless struggled to find sustained momentum, weighed down by lingering concerns over Medicare Advantage margin recovery and, more recently, the shock of losing a senior executive, an event that has triggered internal restructuring and closer scrutiny of governance and security practices.

The result: a company delivering genuinely solid operational improvement, but one whose stock price has yet to fully reflect it.

Technical Analysis of UnitedHealth​

As the UNH daily chart shows, the stock remains in a broader downtrend from July's highs near $459.51, currently testing a critical confluence near $374–383, where the 0.382 Fibonacci retracement and the 200-period EMA all converge. Adding intrigue to the setup, the RSI is forming a bullish divergence, printing higher highs even as price carved a fresh low in recent sessions.

Bullish Scenario

Should buyers break above this EMA-Fibonacci confluence, the divergence would gain real technical credibility, opening the path towards a retest of the broader downtrend structure and potentially challenging the $450–$460 area, where the stock has its recent high in July.

Bearish Scenario

Conversely, a rejection at this confluence would keep sellers in control, invalidating the divergence and exposing the 0.5 retracement near $357.46, with a deeper slide risking a retest of the 0.618 level around $333.37, the support zone that held throughout last autumn and winter.

With price testing a stubborn multi-factor confluence while the RSI quietly hints at fading downside momentum, UnitedHealth's next move looks set to determine whether the fundamental recovery story finally gains technical confirmation, or whether the broader downtrend still has room to run.

Open an account with a true ECN broker

 

[Noah Vance BR]

The RSI divergence is interesting, but blindly front-running mean reversions below the 200 EMA usually backtests terribly in these large-cap trend days.

If we get a clean daily close back above ~$385, defining risk below the recent swing low (~$370) targeting the $440-$450 zone gives a pretty clean 3:1+ R:R. Until that confirmation prints though, the probability of tapping the $357 liquidity pocket is too high to justify stepping in early.

 

[EthanCole]

Spot on. Front-running RSI divergence below a declining 200 EMA is a great way to get chopped up. I've got UNH on my watchlist to see if the 4H can actually print a higher high, but until there's a clear daily market structure shift, sitting on hands is definitely the move. No reason to force a setup here.

 

[JulianCraft]

Honestly, staring at charts right now feels like trying to catch a falling knife while the macro ground keeps shifting under our feet. Inflation prints aren't cooling down the way the bulls hoped, and with sticky price pressures refusing to go away, the Fed is in no position to actually pivot and save the market with rate cuts anytime soon. High borrowing costs and tighter liquidity are going to keep putting pressure on these mega-cap valuations. I wouldn't trust any technical bounce here when the broader liquidity drain is still fully intact.

 

[ArthurByte]

I'm with you guys, catching a knife here is just begging for a stop-out. Everyone is obsessed with the RSI but they're completely missing that massive OB sitting right around $350. If the sellers push it down to clear that liquidity pocket, that’s where the real institutional money is going to step in to defend the level. I'm not touching this until I see a clean BMS on the daily. Don't force it.